Our Psychedelic Trip Isn’t Over I don’t know the first thing about psychedelics. Rather, that’s what I would have been saying back in 2020 when the psychedelics sector…
medical psychedelics
Modern Day Space Race $23.139M Market Capitalization Optimi Health Corp. (OPTI.C) announced today that it has commenced the cultivation of natural GMP-grade psilocybin mushrooms at its Princeton, British Columbia…
Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple…
Not So Generalized Disorder “Anxiety is a part of normal life.” Or so I was told. Whether I was simply leaving my apartment to get food or speaking during…
Filament Health Corp. (FH.NE) (“Filament”) announced today that it will be participating in three conferences throughout December 2021. These conferences include the Horizons: Perspectives on Psychedelics Conference, H.C. Wainwright 2nd…
The World Health Organization (WHO) has listed depression as a leading cause of disability worldwide and a major contributor to the overall global burden of disease. Unfortunately, traditional treatments…
Aion Therapeutics’ (AION.C) proprietary and patented combinatorial mushroom preparations, Aion F7 and Aion F8, have shown high efficacy in killing HER2+ breast cancer cells, ER+/PR+ breast cancer cells, and…
Core One Labs (COOL.C) signed a letter of intent today with Ketamine Infusion Centers of Texas (KICT) today to determine if the company would be an adequate fit for…